Company Description
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally.
The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries.
It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name.
In addition, the company offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories.
Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention; and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads.
It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors.
The company was incorporated in 1970 and is headquartered in Largo, Florida.
| Country | United States |
| Founded | 1970 |
| IPO Date | Jul 23, 1987 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 3,900 |
| CEO | Patrick Beyer |
Contact Details
Address: 11311 Concept Boulevard Largo, Florida 33773-4908 United States | |
| Phone | 727 392 6464 |
| Website | conmed.com |
Stock Details
| Ticker Symbol | CNMD |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000816956 |
| CUSIP Number | 207410101 |
| ISIN Number | US2074101013 |
| Employer ID | 16-0977505 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Patrick J. Beyer | President, Chief Executive Officer and Director |
| Todd W. Garner CPA | Executive Vice President of Finance and Chief Financial Officer |
| Peter K. Shagory | Executive Vice President of Strategy and Corporate Development |
| Curt R. Hartman | Special Advisor |
| Brent Lalomia | Executive Vice President of Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations |
| Andrew Moller | Principal Accounting Officer, Vice President and Corporate Controller |
| Richard Glaze | Chief Information Officer |
| Hollie K. Foust | Executive Vice President, General Counsel and Corporate Secretary |
| Shanna L. Cotti-Osmanski | Executive Vice President of Information Technology and CIO |
| John Ferrell | Executive Vice President of Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 31, 2025 | 10-Q | Quarterly Report |
| Jul 30, 2025 | 8-K | Current Report |
| Jul 18, 2025 | SCHEDULE 13G/A | Filing |
| Jul 7, 2025 | 8-K | Current Report |
| Jun 18, 2025 | 11-K | Annual report of employee stock purchase, savings and similar plans |
| Jun 16, 2025 | 8-K | Current Report |
| May 29, 2025 | SD | Form - SD |
| May 21, 2025 | 8-K | Current Report |
| May 20, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| May 20, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |